Report ID |
136137 |
Drug Identification Number |
02236883 |
Brand name |
LOVENOX |
Common or Proper name |
Lovenox |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
MARKETED |
Active Ingredient(s) |
ENOXAPARIN SODIUM |
Strength(s) |
40MG |
Dosage form(s) |
SOLUTION |
Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
Packaging size |
10 |
ATC code |
B01AB |
ATC description |
ANTITHROMBOTIC AGENTS |
Reason for shortage |
Other (Please describe in comments) |
Anticipated start date |
2021-12-17 |
Actual start date |
|
Estimated end date |
2021-12-20 |
Actual end date |
2021-12-02 |
Shortage status |
Avoided shortage |
Updated date |
2021-12-02 |
Company comments |
Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |